Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Lab ; 65(10)2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31625349

ABSTRACT

BACKGROUND: The pneumonia severity index (PSI) scoring system is one of the tools used to evaluate and predict the prognosis of patients with community-acquired pneumonia (CAP). Although PSI has been widely used in clinical studies of pneumonia, it is still rare to combine it with blood indexes to predict the prognosis of pneumonia. Neutrophil-to-lymphocyte ratio (NLR) is a promising candidate predictor of mortality in CAP patients. The aim of this study was to investigate the efficacy of pneumonia severity index combined with NLR in predicting 30-day mortality in CAP patients. METHODS: We conducted a retrospective study. We analyzed data on 400 non-immune individuals over the age of 18 in this study. All patients received blood routine measurement and PSI score calculation after admission. The primary outcome measures were mortality and survival in CAP patients. The sensitivity and specificity of PSI score, NLR, and the combination of PSI score and NLR in predicting 30-day mortality were assessed using the subject operating characteristic curve (ROC). RESULTS: Data from 400 patients were analyzed, in which the 30-day mortality was 10.5% (42/400). The AUC of NLR and PSI in predicting 30-day mortality of CAP patients were 0.81 (95% CI 0.73 - 0.89) and 0.94 (95% CI 0.90 - 0.98), respectively, with statistically significant differences (p = 0.00). The sensitivity and specificity of NLR were 0.80 and 0.7, respectively. The sensitivity and specificity of PSI were 0.78 and 0.94, respectively. The combined AUC of the two indicators for predicting death in CAP patients was 0.95 (95% CI 0.92 - 0.99), and the sensitivity and specificity were 0.85 and 0.94, respectively. CONCLUSIONS: Neutrophil-to-lymphocyte ratio improves the accuracy and sensitivity of the pneumonia severity index in predicting 30-day mortality of CAP patients.


Subject(s)
Community-Acquired Infections/blood , Hospitalization/statistics & numerical data , Lymphocytes , Neutrophils , Pneumonia/blood , Severity of Illness Index , Adult , Aged , Community-Acquired Infections/diagnosis , Community-Acquired Infections/mortality , Female , Humans , Male , Middle Aged , Pneumonia/diagnosis , Pneumonia/mortality , Prognosis , Retrospective Studies , Sensitivity and Specificity , Survival Rate
2.
Clin Lab ; 65(6)2019 Jun 01.
Article in English | MEDLINE | ID: mdl-31232022

ABSTRACT

BACKGROUND: Invasive pulmonary aspergillosis and nocardia overlap in clinical and radiological presentations, so differentiating between nocardia and invasive pulmonary aspergillosis is confusing. Though sputum culture could distinguish between nocardia and aspergillus fumigatus, but for the ultimate diagnosis, sputum culture provided limited help. Here we report a case of a patient with positive G test and aspergillus fumigatus sputum culture mimic invasive pulmonary aspergillosis ultimately diagnosed as nocardia through bronchoalveolar lavage culture combined metagenomic next-generation sequencing (NGS). METHODS: Bronchoalveolar lavage culture combined metagenomic NGS for infectious diseases were performed for diagnosis. RESULTS: Bronchoalveolar lavage culture combined metagenomic next-generation sequencing showed Nocardia Gelsenkirchen. CONCLUSIONS: Positive G test and sputum culture were not specific, while bronchoalveolar lavage culture and NGS gave more information for a differential diagnosis between nocardia and aspergillus fumigatus.


Subject(s)
Aspergillus fumigatus/isolation & purification , Invasive Pulmonary Aspergillosis/diagnosis , Nocardia Infections/diagnosis , Nocardia/isolation & purification , Sputum/microbiology , beta-Glucans/blood , Aspergillus fumigatus/genetics , Aspergillus fumigatus/physiology , Bronchoalveolar Lavage Fluid/microbiology , Diagnosis, Differential , Female , High-Throughput Nucleotide Sequencing , Humans , Invasive Pulmonary Aspergillosis/microbiology , Limulus Test , Lung/microbiology , Middle Aged , Nocardia/genetics , Nocardia/physiology , Nocardia Infections/microbiology , Sensitivity and Specificity
3.
Clin Lab ; 65(5)2019 May 01.
Article in English | MEDLINE | ID: mdl-31115232

ABSTRACT

BACKGROUND: Elevated adenosine deaminase (ADA) and normal tumor markers in pericardial or pleural effusion are usually considered to be a specific manifestation of benign pericardial or pleural effusion. Here we report a case of lung adenocarcinoma with pericardial metastasis with elevated ADA and normal tumor markers in pericardial effusion. METHODS: Pericardiocentesis and lung puncture combined laboratory indexes and pathology were performed for diagnosis. RESULTS: Analysis of pericardial fluid revealed a white blood cell (WBC) count of 2,000 x 106/L (70% for lymphocytes) with an ADA level of 72.8 U/mL. Pathology of pericardial effusion found no malignant cells. Histopathology of percutaneous lung puncture showed adenocarcinoma. CONCLUSIONS: ADA and tumor markers were not a specific index in differential diagnosis between tuberculosis and metastasis in pericardial effusion.


Subject(s)
Adenocarcinoma/diagnosis , Adenosine Deaminase/metabolism , Lung Neoplasms/diagnosis , Pericardial Effusion/diagnosis , Pericarditis, Tuberculous/diagnosis , Pericardium/pathology , Biomarkers, Tumor/analysis , Diagnostic Errors , Female , Humans , Middle Aged , Pericardial Effusion/metabolism , Pleural Effusion/diagnosis , Pleural Effusion/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...